Workflow
Innospec(IOSP)
icon
Search documents
Innospec(IOSP) - 2022 Q3 - Quarterly Report
2022-11-09 17:32
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or other jurisdic ...
Innospec (IOSP) Investor Presentation - Slideshow
2022-08-24 15:40
Innovating with Our Customers AUGUST 2022 innospec� General Disclosure Use of Non-GAAP Financial Measures The information presented in this presentation includes financial measures that are not calculated or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These nonGAAP financial measures comprise EBITDA, income before income taxes excluding special items, net income excluding special items and related per share amounts together with net cash. EBITDA is net ...
Innospec(IOSP) - 2022 Q2 - Earnings Call Transcript
2022-08-06 19:23
Innospec Inc. (NASDAQ:IOSP) Q2 2022 Earnings Conference Call August 3, 2022 10:00 AM ET Company Participants David Jones - General Counsel & Chief Compliance Officer Patrick Williams - President & Chief Executive Officer Ian Cleminson - Executive Vice President & Chief Financial Officer Conference Call Participants Mike Harrison - Seaport Research Partners Stefanos Crist - CJS Securities David Jones [Call starts abruptly] This is David Jones. I'm Innospec's General Counsel and Chief Compliance Officer. Late ...
Innospec(IOSP) - 2022 Q2 - Quarterly Report
2022-08-03 15:02
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or other jurisdiction ...
Innospec(IOSP) - 2022 Q1 - Earnings Call Transcript
2022-05-08 17:11
Innospec Inc. (NASDAQ:IOSP) Q1 2022 Earnings Conference Call May 4, 2022 9:00 AM ET Company Participants Patrick Williams - President and Chief Executive Officer Ian Cleminson - Executive Vice President and Chief Financial Officer David Jones - Senior Vice President and Chief Compliance Officer Conference Call Participants Mike Harrison - Seaport Research Partners Jon Tanwanteng - CJS Securities David Silver - CL King & Associates Chris Shaw - Monness, Crespi, Hardt & Co. David Jones Thank you. Late yesterd ...
Innospec(IOSP) - 2022 Q1 - Earnings Call Presentation
2022-05-06 06:09
Q1 2022 Earnings 1 May 2022 innospec》 Forward Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "estimates," "anticipates," "may," "could," "believes," "feels," "plans," "intends" or sim ...
Innospec(IOSP) - 2022 Q1 - Quarterly Report
2022-05-04 15:05
Table of Contents Commission file number 1-13879 INNOSPEC INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or other jurisdiction ...
Innospec(IOSP) - 2021 Q4 - Earnings Call Presentation
2022-02-17 06:56
innospec� chemistry matters Q4 2021 Earnings FEBRUARY 2022 Forward Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "estimates," "anticipates," "may," "could," "believes," "feels," "pla ...
Innospec(IOSP) - 2021 Q4 - Earnings Call Transcript
2022-02-16 17:44
Innospec Inc. (NASDAQ:IOSP) Q4 2021 Earnings Conference Call February 16, 2022 10:00 AM ET Company Participants Patrick Williams – President and Chief Executive Officer Ian Cleminson – Executive Vice President and Chief Financial Officer David Jones – Senior Vice President and Chief Compliance Officer Conference Call Participants Jon Tanwanteng – CJS Securities Operator Good day and thank you for standing by. Welcome to the Innospec's Fourth Quarter, 2021, Earnings Release and Conference Call. At this time, ...
Innospec(IOSP) - 2021 Q4 - Annual Report
2022-02-16 16:04
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITIONREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) | DELAWARE 98-0181725 | | | --- | --- | | State or othe ...